Aspira Women's Health Inc (NASDAQ:AWH) is set to release its Q3 2024 earnings on Nov 14, 2024. The consensus estimate for Q3 ...

Aspira Womens Health Inc (AWH) reports growth in test volumes and secures a $10 million federal award, despite ...

Separately, Alliance Global Partners lowered their price objective on shares of Aspira Women’s Health from $7.00 to $5.50 and set a “buy” rating on the stock in […] ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on AWH: Aspira Women's Health ...

The stock of Aspira Women’s Health Inc (AWH) has gone up by 13.62% for the week, with a 5.45% rise in the past month and a -38.99% drop in the past quarter. The volatility ratio for the week is 8.98%, ...

On Wednesday, Aspira Women’s Health Inc (AWH) stock saw a decline, ending the day at $0.98 which represents a decrease of $-0.09 or -8.41% from the prior close of $1.07. The stock opened at $1.04 and ...

Ellen Beausang, Chief Commercial Officer of BioReference, shared the excitement, emphasizing how the addition of OvaWatch to the Women's Health portfolio underscores BioReference Health's commitment ...

AUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a bio-analytical based women’s health company focused on the development of ...

About Aspira Women’s Health Inc. Aspira Women’s Health Inc. is dedicated to the discovery, development, and commercialization of noninvasive, AI-powered tests to aid in the diagnosis of gyn ...

Please click one button to see how the community sees this security. A loss of -1.890% shows a downward development for Aspira Womens Health Inc.. The community is currently still undecided about ...

AUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a bio-analytical based women’s health ...